How large is the parathyroid hormone market, and what is its growth trajectory?
The parathyroid hormone market size has grown steadily in recent years. It will grow from $2.35 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing awareness of parathyroid hormone-related disorders, growing demand for parathyroid hormone analogs, increased government funding for parathyroid hormone research, rising disposable incomes.
The parathyroid hormone market size is expected to see strong growth in the next few years. It will grow to $3.5 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing geriatric population, expansion of private healthcare sectors, emerging indications, precision medicine, growing awareness of bone health, expanding healthcare access. Major trends in the forecast period include advances in parathyroid hormone testing, advances in drug delivery, combination therapies, digital health integration, sustainability and green initiatives.
Get Your Free Sample of The Global Parathyroid Hormone Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp
What are the key forces behind the parathyroid hormone market’s growth in recent years?
The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones. Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, which further leads to an increased risk of fracture. For instance, in January 2023, according to the International Osteoporosis Foundation, osteoporosis affects approximately 1.4 million Canadians, mainly postmenopausal women and the elderly. The parathyroid hormone, which is naturally produced by the body for regulating calcium levels, is used to reduce the risk of bone fracture in people with osteoporosis and is administered as a daily subcutaneous injection. The increase in osteoporosis is therefore expected to contribute to the growth of the parathyroid hormone market.
What are the major segments of the parathyroid hormone market?
The parathyroid hormone market covered in this report is segmented –
1) By Disease Type: Hypocalcemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report
Which companies dominate the parathyroid hormone market?
Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited
Which market trends are set to define the future of the parathyroid hormone market?
Major companies operating in the parathyroid hormone market are focusing on developing biosimilars of parathyroid-based drugs, such as prodrugs of parathyroid hormone (PTH), to enhance treatment options. A prodrug of parathyroid hormone (PTH) is an inactive compound that transforms into active parathyroid hormone after administration, enabling prolonged release and stable therapeutic outcomes for calcium regulation and bone health. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company announced that the Food & Drug Administration (FDA), approved YORVIPATH (palopegteriparatide) as the first and only treatment for hypoparathyroidism in adults. This once-daily prodrug ensures continuous exposure to PTH, benefiting an estimated 70,000 to 90,000 patients in the United States. Ascendis Pharma, the manufacturer, provides patient support through its ascendis signature access program (A.S.A.P.) program, but users must regularly monitor serum calcium levels for potential hypercalcemia or hypocalcemia.
Which regional trends are influencing the parathyroid hormone market, and which area dominates the industry?
North America was the largest region in the parathyroid hormone market in 2024. The Middle East is expected to be the fastest-growing region in the global parathyroid hormone market share during the forecast period. The regions covered in the parathyroid hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Parathyroid Hormone Market Report 2025 Offer?
The parathyroid hormone market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Parathyroid hormone refers to a substance produced by the parathyroid gland that aids in the body’s storage and utilization of calcium. High blood calcium levels are a result of parathyroid hormone levels that are greater than usual and could be a disease indicator. It is also known as PTH, parathyrin, and parathormone.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3427
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
